#hiv-prevention

[ follow ]

Biden proposes new rule eliminating cost sharing for injectable PrEP

The Biden administration proposed a new rule mandating insurers to provide injectable PrEP drugs without cost-sharing to increase HIV prevention access.

Session 3: NIMH 75th Anniversary Event 3

The integration of cultural and identity considerations is vital in health interventions for marginalized communities.
#lenacapavir

A new way to prevent HIV delivers dramatic results in trial

Lenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.

Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'

Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.

Doctor behind trial of HIV prevention drug recounts breakthrough moment

A new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.

Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do it

Lenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.
It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.

Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation

Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.

A new way to prevent HIV delivers dramatic results in trial

Lenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.

Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'

Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.

Doctor behind trial of HIV prevention drug recounts breakthrough moment

A new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.

Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do it

Lenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.
It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.

Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation

Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
morelenacapavir
#public-health

Dr. Demetre Daskalakis, the White House's mpox response deputy coordinator, sure knows how to get our attention - Queerty

Dr. Daskalakis is a key figure in HIV prevention and public health advocacy, especially within the LGBTQ+ community.

Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEP

Delays in accessing HIV Pre-Exposure Prophylaxis (PrEP) have been reported, despite high demand and its effectiveness in reducing infection risk.

HIV groups criticise decision not to recommend long-acting PrEP for NHS use

NICE's decision against recommending CAB-LA limits access to HIV prevention methods for underserved populations in the UK.

Dr. Demetre Daskalakis, the White House's mpox response deputy coordinator, sure knows how to get our attention - Queerty

Dr. Daskalakis is a key figure in HIV prevention and public health advocacy, especially within the LGBTQ+ community.

Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEP

Delays in accessing HIV Pre-Exposure Prophylaxis (PrEP) have been reported, despite high demand and its effectiveness in reducing infection risk.

HIV groups criticise decision not to recommend long-acting PrEP for NHS use

NICE's decision against recommending CAB-LA limits access to HIV prevention methods for underserved populations in the UK.
morepublic-health

Australia running low on HIV-prevention drug PrEP as experts warn users to plan ahead

Australia faces a shortage of PrEP medication crucial for HIV prevention, prompting calls for users to plan ahead.
#prep

New HIV preventive strategy sparks excitement and protests at AIDS conference

The new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.

Injectable HIV medication: What you need to know DW 07/19/2024

Injectable cabotegravir offers a new option in HIV prevention and treatment.

A Fading Weapon in the H.I.V. Fight: Condoms

Decline in condom use among gay and bisexual men, especially young and Hispanic individuals
Public health focus on PrEP may have overshadowed condom promotion

An "ultra" PrEP injection just three times a year could be on the way

Approval of new PrEP injection with potentially longer dosing intervals
Results of trial for cabotegravir ultra long-acting formulation presented at CROI 2024

New HIV preventive strategy sparks excitement and protests at AIDS conference

The new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.

Injectable HIV medication: What you need to know DW 07/19/2024

Injectable cabotegravir offers a new option in HIV prevention and treatment.

A Fading Weapon in the H.I.V. Fight: Condoms

Decline in condom use among gay and bisexual men, especially young and Hispanic individuals
Public health focus on PrEP may have overshadowed condom promotion

An "ultra" PrEP injection just three times a year could be on the way

Approval of new PrEP injection with potentially longer dosing intervals
Results of trial for cabotegravir ultra long-acting formulation presented at CROI 2024
moreprep

I Kissed A Boy star appears in HIV documentary following vaccine trial

Raising awareness about HIV prevention and the importance of PrEP is crucial to ending new cases of the virus by 2030.

HIV transmissions down by 12%. One age group in particular is bringing those numbers down. - LGBTQ Nation

HIV infections among men decreased by 12% from 2018 to 2022, with the largest decline seen in men aged 13 to 24.
#healthcare-access

Opinion: Give Californians same medication access that Australians, Canadians, Coloradans enjoy

California expands access to PrEP and PEP medications without doctor's prescription.
Canada and Australia showcase successful pharmacist prescribing models for common conditions.

Transgender women have a higher risk of HIV infections. A new CDC report reveals why

Transgender women have disproportionately high rates of HIV and have been excluded from HIV prevention research.
Discrimination and lack of access to healthcare are the main causes behind the high rate of HIV infections in transgender women.

Opinion: Give Californians same medication access that Australians, Canadians, Coloradans enjoy

California expands access to PrEP and PEP medications without doctor's prescription.
Canada and Australia showcase successful pharmacist prescribing models for common conditions.

Transgender women have a higher risk of HIV infections. A new CDC report reveals why

Transgender women have disproportionately high rates of HIV and have been excluded from HIV prevention research.
Discrimination and lack of access to healthcare are the main causes behind the high rate of HIV infections in transgender women.
morehealthcare-access

Should California schools have to share sex ed materials online? One lawmaker says yes

Republican lawmaker introduces bill to require online publication of sex education materials in California schools
The bill aims to foster collaboration between parents and schools on a sensitive subject

HIV still plagues Black Americans at alarming rates. Could AI be the key to more equitable care?

Job discrimination and structural stressors contribute to higher risk behavior for HIV in non-white communities.
New technologies and innovations offer solutions to bridge disparities in HIV incidences and increase uptake in preventative measures.

HIV cases are increasing among younger queer Latinos. Here's why. - LGBTQ Nation

Young Latino men have a rising share of new HIV infections, despite being a minority in the U.S. population.

New Drug Provides Total Protection From H.I.V. in Trial of Young African Women

Twice-yearly injection of lenacaprivir provided total protection against H.I.V. in a clinical trial in Africa.

Green Party removes HIV image from online manifesto after backlash

The Green Party faced backlash for an image in its manifesto depicting people with HIV as coughing, later replaced with a hand holding a pill.
[ Load more ]